CREG2’s role in cancer is complex, with some studies suggesting it may have a pro-cancer effect by influencing stromal cells and proliferation, while other research has identified it as a potential prognostic biomarker that could help in predicting patient outcomes and guiding personalized treatment strategies. The gene discussed is CREG2; the disease is cancer.